Prenatal Genetic Testing Market Competitive Analysis Cepheid, ELITech Group, Autogenomics, Sequenom, GeneDx, 23andMe, Inc., Ambry Genetics

Prenatal Genetic Testing Market report works very well for initiating and enhancing the strategies for sales, advertising, marketing, and promotion. SWOT analysis has been applied in the report which highlights the global key manufacturers, market definition, description and analysis of the market competition landscape along with many other factors. Competitor strategies such as new product launches, expansions, agreements, joint ventures, partnerships, and acquisitions helps the industry to take better steps for selling goods and services. Prenatal Genetic Testing Market research report has the best answers to many of the critical business questions and challenges.

Global Prenatal Genetic Testing Market By Technology {Diagnostics Methods (PCR, aCGH, FISH), Screening methods (Non-Invasive Prenatal Tests, Maternal Serum Screening)}, Screening Techniques (Carrier screening, sequential screening, and maternal serum quad screening), Diseases (Alzheimer’s Disease, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington’s Disease, Rare Diseases, Other Diseases), End User (Hospitals, Clinics, Diagnostic Centers), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

To Get Sample Copy of Report, Click Here @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-prenatal-genetic-testing-market

Global Prenatal Genetic Testing Market is expected to rise gradually to an estimated value of USD 92.32 billion by 2026, registering a CAGR of 29.2% in the forecast period of 2019-2026 with the annual sales of USD 11.89 billion in year 2018.

Few of the major competitors currently working in the dosage cups market are Bio-Rad Laboratories Inc. (US), Agilent Technologies Inc. (US), Illumina, Inc (US), Natera Inc. (US) Abbott (US), Cepheid (US), ELITech Group (France), Autogenomics (US),   Sequenom (US), GeneDx (US), 23andMe, Inc. (US), Ambry Genetics (US), Invitae Corporation (US), Pathway Genomics (US), Progenity, Inc. (US), and few among others.

Key Developments in the Market:

On 7thNovember 2017, Progenity announced Closing of $125 Million Financing for Prenatal-Women’s Health Genetics and Gastrointestinal/Inflammatory Bowel Disease Precision Medicine. The financing was led by a fund managed by an existing investor, Athyrium Capital Management.
On 30thApril, 2019, HTG Molecular Diagnostics, Inc., a diagnostic company whose mission is to advance precision medicine, announced that it has amended its IVD Test Development and Component Supply Agreement with Illumina, Inc. (Illumina). It will help company to grow in the market.

Market Definition: Global Prenatal Genetic Testing Market

Prenatal testing enables us to detect the problems associated with the pregnancy. Prenatal genetic testing is done to know the birth defects such as Down syndrome, Trisomy 13, Trisomy 18 and others that are associated with genetic disorder of an unborn child before birth or during pregnancy.

According to World Health Organization, about 2%-5% of all live births, account for up to 30% of pediatric hospital admissions and cause about 50% of childhood deaths in industrialized countries, almost more than half of these deaths could have been avoided with the availability of proper medical equipment and devices for healthcare procedures. This significant number is expected to act as a driver to market growth.

Market Drivers

Increasing prevalence of genetic diseases such as down syndrome, edward syndrome and patau syndrome and rising awareness among population.
Rising demand for prenatal testing for identifying genetic abnormalities.
Increasing approaches for novel diagnostic techniques and tools.

Market Restraints

High test costs make it unaffordable for the middle class people.
High skilled professionals are required.

Request for Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-prenatal-genetic-testing-market

Segmentation: Global Prenatal Genetic Testing Market

By Technology

Diagnostics Methods
PCR
aCGH
FISH
Screening Techniques
Non-Invasive Prenatal Tests
Maternal Serum Screening

By Screening Techniques

Carrier screening
Sequential screening
Maternal serum quad screening

By End Users

Hospitals
Clinics
Diagnostic centers

By Diseases

Alzheimer’s Disease
Cancer
Cystic Fibrosis
Sickle Cell Anemia
Duchenne Muscular Dystrophy
Thalassemia
Huntington’s Disease
Rare Diseases
Other Diseases

By Geography

North America
US
Canada
Mexico
South America
Brazil
Argentina
Rest of South America
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Turkey
Belgium
Netherlands
Switzerland
Rest of Europe
Asia-Pacific
Japan
China
South Korea
India
Australia
Singapore
Thailand
Malaysia
Indonesia
Philippines
Rest of Asia Pacific
Middle East & Africa
South Africa
Egypt
Saudi Arabia
United Arab Emirates
Israel
Rest of Middle East & Africa

Competitive Analysis: Global Prenatal Genetic Testing Market

Global prenatal genetic testing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of prenatal genetic testing for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

Current and future of global prenatal genetic testing market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Inquiry Before Buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-prenatal-genetic-testing-market

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

This release was published on openPR.